2006
Validity of the Autism Diagnostic Interview-Revised
Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, Lee LS, Kau AS. Validity of the Autism Diagnostic Interview-Revised. American Journal On Intellectual And Developmental Disabilities 2006, 111: 199-215. PMID: 16597187, DOI: 10.1352/0895-8017(2006)111[199:votadi]2.0.co;2.Peer-Reviewed Original Research
2005
Child Psychopharmacology, Effect Sizes, and the Big Bang
Martin A, Gilliam WS, Bostic JQ, Rey JM. Child Psychopharmacology, Effect Sizes, and the Big Bang. American Journal Of Psychiatry 2005, 162: 817-a-817. PMID: 15800175, DOI: 10.1176/appi.ajp.162.4.817-a.Peer-Reviewed Original Research
2000
Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network
Arnold L, Aman M, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman B, Gates-Ulanet P, Klin A, McCracken J, McDougle C, McGough J, Posey D, Scahill L, Swiezy N, Ritz L, Vokmar F. Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network. Journal Of Autism And Developmental Disorders 2000, 30: 99-111. PMID: 10832774, DOI: 10.1023/a:1005451304303.Peer-Reviewed Original ResearchMeSH KeywordsAntipsychotic AgentsAutistic DisorderChildHumansNeuropsychological TestsReproducibility of ResultsRisperidoneTreatment OutcomeConceptsAutism Diagnostic InterviewChildren/adolescentsAutistic disorders symptomsNeuropsychological testsDisorder symptomsLower functioningAutistic disorderCore featuresTest developersDiagnostic InterviewProblem presentationPediatric psychopharmacologyAutismIndividual changesTreatment respondersTarget symptomsSecondary symptomsCommunication problemsMethodological challengesAssessment strategiesSubject heterogeneityIQPharmacological treatmentDisordersClinical Global Impression